Initial cell viability experiments in NB cell lines showed one of these agents, the EWS-FLI1/RNA helicase A (RHA) interaction inhibitor YK-4-279, obviously inhibited the growth of NB cells in vitro, while the others did not. This evidence concerns the gene FLI1 and neuroblastoma.